Clinical Trial Update: Telomerase Activity as a Marker For Mobilization Quality

View source ↗

Summary

This clinical trial update discusses telomerase activity as a biomarker to assess mobilization quality in patients with lymphoma or multiple myeloma. The sponso…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma
• Multiple Myeloma

Snippet

Sponsor: Rabin Medical Center | Conditions: Lymphoma, Multiple Myeloma | Status: UNKNOWN